Trading Signals: BCRX Stock Price Prediction and Forecast (Tue. Sep. 2, 2003 - Wed. Sep. 27, 2023)(BioCryst Pharmaceuticals, Inc.)
| BCRX latest price $7.6750 (5.79%) ($7.6750 - $7.6900) on Tue. Dec. 8, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 5.2% (three month average) | RSI | 81 | Latest Price | $7.6750(5.79%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BCRX advances 10.1% a day on average for past five trading days. | Weekly Trend | BCRX advances 21.2% a week on average for past two weeks. | Market Behavior | Value stock rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support BCRX advance at 0% a week (0% probability) ARKK(5%) XRT(5%) VIXM(4%) ARKG(3%) IBUY(3%) | Factors Impacting BCRX price | BCRX will decline at least -2.6% in a week (0% probabilities). XLP(-10%) XLV(-8%) XLK(-8%) VUG(-7%) UNG(-7%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | | | | Market Trend Strength | -2.6% (StdDev 5.2%) | Hourly BBV | 1.5 () | Intraday Trend | 0% | | | |
|
Inflection Point | Yes | 5 Day Moving Average | $6.24(23%) | 10 Day Moving Average | $5.62(36.57%) | 20 Day Moving Average | $4.99(53.81%) | To recent high | 0% | To recent low | 52.4% | Market Cap | $1.354b | | | | BioCryst Pharmaceuticals, Inc. designs and develops novel, oral and small-molecule medicines. Its drug candidates include Berotralstat, BCX9930, BCX9250, RAPIVAB, ALPIVAB, RAPIACTA, PERAMIFLU, Galidesivir and Mundesine. The company was founded in 1986 and is headquartered in Durham, NC. |